Amid recent revelations that EpiPen maker Mylan has been overcharging U.S. taxpayers for potentially hundreds of millions of dollars since at least 2011, the drug company says it has agreed to pay $465 million to close the book on a federal investigation into its Medicaid pricing — all without admitting any liability. [More]
not quite settled
Mylan To Pay $465M To Settle EpiPen Medicaid Pricing Scandal; Critics Call Deal “Inadequate”
By 10.7.16 — Updated: 10.24.16
Merck Agrees To Pay $100 Million To Settle NuvaRing Lawsuits
By 2.7.14
There are thousands of pending lawsuits against big pharma biggie Merck involving its NuvaRing birth control product and whether its marketing downplayed the risk of blood clots to women who use it. Today, Merck announced that it’s agreed to pay out $100 million to settle these claims, but that will require almost all of the eligible plaintiffs to sign off on the deal. [More]
More Than 2 Years Later, Court Finally Signs Off On $8.5 Billion Settlement… Sort Of
By 1.31.14
In June 2011, Bank of America reached an $8.5 billion settlement deal with 22 groups of investors who had been misled into sinking their money into securities that they didn’t know were backed by worthless home mortgages. Today, more than two-and-a-half years later, it appears that this matter may be nearing an end, but maybe not. [More]
